PD-L1 expression is also higher in patients with epidermal growth factor receptor (EGFR)-mutated NSCLC tumors than with EGFR-wild-type (WT) tumors [4, 5]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.